Error in Conclusions - Summary - MDSpire

Error in Conclusions

  • May 1, 2026

  • 0 min

Share

Objective:

To correct the conclusions of a clinical trial comparing extended-release and sublingual buprenorphine in pregnant adults with opioid use disorder (OUD).

Key Findings:
  • Pregnant adults with OUD receiving extended-release buprenorphine had higher rates of illicit opioid abstinence compared to those receiving sublingual buprenorphine.
Interpretation:

The correction clarifies the efficacy of extended-release buprenorphine in promoting abstinence from illicit opioids during pregnancy.

Limitations:
Conclusion:

The article has been corrected to accurately represent the trial's conclusions.

Original Source(s)

Error in Conclusions

  • May 1, 2026

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds

Post-Dobbs Mortality Trends Remain Unclear

National cohort shows smaller mortality declines in ban states and divergent patterns by race and geography.